Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abaxis Inc (ABAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,423,744
  • Shares Outstanding, K 22,700
  • Annual Sales, $ 227,220 K
  • Annual Income, $ 32,720 K
  • 36-Month Beta 0.86
  • Price/Sales 6.11
  • Price/Cash Flow 37.28
  • Price/Book 5.01

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.58 +32.40%
on 01/02/18
64.45 -0.20%
on 01/23/18
+14.71 (+29.65%)
since 12/22/17
3-Month
45.00 +42.93%
on 11/09/17
64.45 -0.20%
on 01/23/18
+17.27 (+36.71%)
since 10/23/17
52-Week
43.66 +47.32%
on 09/19/17
64.45 -0.20%
on 01/23/18
+16.06 (+33.28%)
since 01/23/17

Most Recent Stories

More News
Abaxis, Inc. Announces USDA Approval of New VetScan FLEX4 Rapid Test

Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary markets worldwide, today announced that the USDA, Center...

ABAX : 64.32 (+2.55%)
Abaxis To Report Third Quarter Fiscal Year 2018 Financial Results On Thursday, January 25, 2018

Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, has scheduled a conference...

ABAX : 64.32 (+2.55%)
Abaxis' Product Line Expansion Aids Growth, Rivalry Rife

Abaxis' (ABAX) growing portfolio of rapid test menu and a strong performance in Veterinary consumables drive growth. Intense competition in both the Medical and Veterinary markets is a concern.

ABAX : 64.32 (+2.55%)
MOH : 92.27 (+0.33%)
BIO : 254.83 (+0.07%)
CNC : 110.97 (-0.56%)
Abaxis' (ABAX) Preliminary Results for Q3 Cheer Investors

Abaxis (ABAX) expects substantial tax savings from the recent U.S. tax reform.

ITGR : 49.85 (+0.20%)
ABAX : 64.32 (+2.55%)
BIO : 254.83 (+0.07%)
ISRG : 439.55 (+1.29%)
Abaxis Reports Preliminary Financial Performance for the Third Quarter of Fiscal 2018

Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported preliminary...

ABAX : 64.32 (+2.55%)
Abaxis, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference

Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary markets worldwide, announced today that Clint Severson,...

JPM : 114.21 (-0.10%)
ABAX : 64.32 (+2.55%)
Abaxis Well Poised on Solid Prospects, Competition Rife

Abaxis' (ABAX) new sales and marketing strategies boost investors' confidence.

CHE : 268.05 (+0.19%)
AMED : 55.83 (-1.31%)
ABAX : 64.32 (+2.55%)
BRKR : 35.07 (unch)
New Strong Sell Stocks for December 7th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

MMS : 69.20 (-0.73%)
ATKR : 23.44 (+1.17%)
ABAX : 64.32 (+2.55%)
ARTX : 3.55 (unch)
INSW : 18.19 (-0.33%)
ABAXIS (ABAX) Up 6.7% Since Earnings Report: Can It Continue?

ABAXIS (ABAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ABAX : 64.32 (+2.55%)
Abaxis, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference

Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that...

ABAX : 64.32 (+2.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Their mission is to improve the efficiency of...

See More

Key Turning Points

2nd Resistance Point 65.89
1st Resistance Point 65.11
Last Price 64.32
1st Support Level 62.88
2nd Support Level 61.43

See More

52-Week High 64.45
Last Price 64.32
Fibonacci 61.8% 56.51
Fibonacci 50% 54.06
Fibonacci 38.2% 51.60
52-Week Low 43.66

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.